Literature DB >> 26177317

Poorly Differentiated and Undifferentiated Thyroid Carcinomas.

Catarina Eloy1, Luciana Ferreira, Catarina Salgado, Paula Soares, Manuel Sobrinho-Simões.   

Abstract

Thyroid cancer is the most common endocrine malignancy and its incidence goes on increasing worldwide. The majority of thyroid tumours comprise well-differentiated (papillary and follicular) thyroid carcinomas that usually carry an excellent prognosis, while a minority progress to poorly differentiated carcinoma (PDTC) and, ultimately, to the highly aggressive and lethal undifferentiated carcinoma (UTC). Recently, some major advances have been made on the histologic and imunohistochemical identification, as well as on the molecular characterization of PDTC and UTC. In this review we summarize the most recent immunohistochemical and molecular findings in PDTC and UTC, giving a particular emphasis to the diagnostic and prognostic meaning of the genetic alterations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26177317     DOI: 10.5146/tjpath.2015.01314

Source DB:  PubMed          Journal:  Turk Patoloji Derg        ISSN: 1018-5615


  8 in total

1.  Circulating BRAFV600E Levels Correlate with Treatment in Patients with Thyroid Carcinoma.

Authors:  Carrie C Lubitz; Tiannan Zhan; Viswanath Gunda; Salma Amin; Benjamin J Gigliotti; Abbey L Fingeret; Tammy M Holm; Heather Wachtel; Peter M Sadow; Lori J Wirth; Ryan J Sullivan; David J Panka; Sareh Parangi
Journal:  Thyroid       Date:  2018-02-27       Impact factor: 6.568

2.  Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer.

Authors:  Tiemo S Gerber; Arno Schad; Nils Hartmann; Erik Springer; Ulrich Zechner; Thomas J Musholt
Journal:  Endocr Connect       Date:  2017-11-13       Impact factor: 3.335

3.  A rare case of poorly differentiated thyroid carcinoma probably arising from a nodular goiter.

Authors:  Hironao Yasuoka; Yasushi Nakamura; Mitsuyoshi Hirokawa; Ken-Ichi Yoshida; Kana Anno; Masayuki Tori; Masahiko Tsujimoto
Journal:  BMC Clin Pathol       Date:  2017-06-02

4.  Management and Prognostic Factors for Thyroid Carcinoma Showing Thymus-Like Elements (CASTLE): A Case Series Study.

Authors:  Rui Gao; Xi Jia; Ting Ji; Jinteng Feng; Aimin Yang; Guangjian Zhang
Journal:  Front Oncol       Date:  2018-10-26       Impact factor: 6.244

5.  Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma.

Authors:  Haruhiko Yamazaki; Hiroyuki Iwasaki; Nobuyasu Suganuma; Soji Toda; Katsuhiko Masudo; Hirotaka Nakayama; Yasushi Rino; Munetaka Masuda
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-10-01

6.  Mediastinal Thyroid Carcinoma and Graves' Disease: A Rare Presentation.

Authors:  Sara Lomelino Pinheiro; Inês Damásio; Ana Figueiredo; Tiago Nunes da Silva; Valeriano Leite
Journal:  Case Rep Endocrinol       Date:  2021-10-12

7.  In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines.

Authors:  Enke Baldini; Dario Presutti; Pasqualino Favoriti; Simonetta Santini; Giuliana Papoff; Chiara Tuccilli; Raffaella Carletti; Cira Di Gioia; Eleonora Lori; Iulia Catalina Ferent; Federica Gagliardi; Antonio Catania; Daniele Pironi; Domenico Tripodi; Vito D'Andrea; Salvatore Sorrenti; Giovina Ruberti; Salvatore Ulisse
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

8.  Thyroid Cancer Metabolism: A Review.

Authors:  Kurren S Gill; Patrick Tassone; James Hamilton; Nikolaus Hjelm; Adam Luginbuhl; David Cognetti; Madalina Tuluc; Ubaldo Martinez-Outschoorn; Jennifer M Johnson; Joseph M Curry
Journal:  J Thyroid Disord Ther       Date:  2016-01-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.